EQUITY RESEARCH MEMO

iSono Health

Generated 5/9/2026

Executive Summary

Conviction (model self-assessment)65/100

iSono Health is a San Francisco-based medical device company that developed the ATUSA scanner, an automated 3D breast ultrasound system designed for point-of-care use. The ATUSA scanner automatically captures the entire breast volume, enabling repeatable imaging without requiring a trained ultrasound operator. This innovation addresses key limitations of traditional breast ultrasound—operator dependence and lack of standardization—and provides physicians with advanced 3D visualization for confident diagnosis and monitoring. Founded in 2018, iSono Health targets the large and underserved breast cancer screening and diagnostics market. With its focus on accessibility and ease of use, the ATUSA scanner has the potential to expand ultrasound utilization in primary care, radiology, and women's health settings. The company has yet to disclose total funding or valuation, indicating an early commercial stage. However, its technology fills a clear gap in breast imaging, particularly for dense breast tissue where mammography is less effective. Commercial traction, regulatory milestones, and strategic partnerships will be key to its growth.

Upcoming Catalysts (preview)

  • Q2 2025FDA 510(k) clearance for ATUSA scanner80% success
  • Q4 2025Strategic partnership or distribution agreement with a major imaging or women's health company50% success
  • Q3 2025Series A or later funding round to scale commercial operations60% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)